Yuya Seko

22PUBLICATIONS
108CO-AUTHORS
Predictive and prognostic markersNgā kura kaupapa Māori (Māori primary education)Medical biotechnology diagnostics (incl. biosensors)Te ariā o ngā tauira panoni hauora o te Māori (Māori theory of change models for health)Metabolic medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|May 12, 2026
Evidence-Based Clinical Practice Guidelines for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) 2026.

|Apr 15, 2026
Management of MASLD/MASH: challenges, innovations, and the future of patient-centered care in Japan.

|Mar 12, 2026
Optimizing VCTE and ELF Thresholds for Treatment-Eligible F2-F3 Fibrosis in Japanese Patients With MASLD.

Yuya Seko, Taeang Arai, Hirokazu Takahashi

|Nov 27, 2025
Impact of PNPLA3 Genotype on Hepatic Steatosis Response to Pemafibrate in MASLD With Dyslipidemia.

Takao Shirono, Yuya Seko, Seita Kataoka

|Dec 13, 2024
Accuracy of type IV collagen 7S versus Enhanced Liver Fibrosis score for diagnosing fibrosis in patients with metabolic dysfunction-associated steatotic liver disease.

Hiroshi Ishiba, Hideki Fujii, Yoshihiro Kamada

|Nov 14, 2024
Impact of PNPLA3 in Lean Individuals and in Cryptogenic Steatotic Liver Disease.

Yuya Seko, Huapeng Lin, Vincent Wai-Sun Wong

Pageof 4

Frequent Collaborators

9 joint publications

Takeshi Okanoue

8 joint publications

Yoshito Itoh

7 joint publications

Kanji Yamaguchi

3 joint publications

Seita Kataoka